Japan’s pharmaceutical industry - the world’s third largest by market value after the United States and China - has long been associated with methodical development cycles and rigorous technical ...

Traditionally, pharmaceutical companies’ interactions with healthcare professionals (HCPs) have been highly personalized — primarily via face-to-face, in-office visits. Recently, however, this model ...

It happens with regularity during citizen open-mike sessions at FDA drug advisory committee hearings. A queue of “patients” materializes out of nowhere to testify, often in tears, about the crucial ...

Forbes contributors publish independent expert analyses and insights. I write about business model strategy and execution across healthcare. The pharmaceutical industry is in the midst of profound ...

Just when the appetite for European biotech was showing signs of a healthy recovery from the 2001 venture fallout, along comes a recession. But with LP appetite for the buyout market at an all-time ...

PHILADELPHIA--(BUSINESS WIRE)--Big Pharma's dependence on traditional executive compensation plans threatens to work in opposition to the very "medicine" of innovation that could restore the sector's ...

Hyderabad-based HRV Pharma is attempting to redefine the traditional pharmaceutical business model by building an active pharmaceutical ingredient (API) company without owning any manufacturing ...

New active pharmaceutical ingredients lay the foundations for innovative and better medical treatments. However, identifying them and, above all, producing them through chemical synthesis in the ...

Influenza Artificial Intelligence model build completedCytoReason analysis of human challenge trial data on track to deliver outputs in Q2 2023 LONDON, UK / ACCESSWIRE / November 29, 2022 / Poolbeg ...